Evolva brings natural sugar blocker to market

Evolva, a biotech company headquartered in Reinach in the canton of Basel-Landschaft, has presented its new product L-arabinose, a natural sugar blocker. According to a press release, studies have demonstrated the effect of L-arabinose on adjusting to a healthy blood sugar level. The sugar blocker can also help with maintaining a healthy weight, for example by foregoing food and drink that contains a lot of sugar. L-arabinose is created by fermentation and is a good substitute for sugar in products such as yogurt, chocolate, soft drinks, ice cream, cereals, energy bars, and confectionary. The company’s press release states that its effect as a reducing sugar means that it can be used to create salty and savory chicken and beef flavors.

Oliver Walker, CEO of Evolva, is quoted as saying: “As people around the world continue to strive to live a healthier lifestyle, we are committed to helping our customers create healthier, more sustainable solutions. With this launch we are confirming our ability to deliver innovations that support human health and wellbeing.”

This new, natural sugar blocker is also of economic interest. Evolva has a current market volume of 250 million Swiss francs, and market growth of around 5 percent per year is anticipated. Evolva has revealed that marketing discussions are already underway with major clients.